US Bancorp’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.3K Buy
2,977
+959
+48% +$10.3K ﹤0.01% 2855
2026
Q1
$17.1K Buy
2,018
+799
+66% +$8.74K ﹤0.01% 3180
2025
Q4
$13.8K Sell
1,219
-81
-6% -$1K ﹤0.01% 3222
2025
Q3
$19.5K Sell
1,300
-905
-41% -$13.2K ﹤0.01% 3082
2025
Q2
$31.1K Sell
2,205
-2,632
-54% -$46.9K ﹤0.01% 2999
2025
Q1
$116K Buy
4,837
+1,866
+63% +$65.8K ﹤0.01% 2323
2024
Q4
$111K Buy
2,971
+798
+37% +$37.2K ﹤0.01% 2345
2024
Q3
$109K Buy
2,173
+790
+57% +$30.7K ﹤0.01% 2355
2024
Q2
$48K Sell
1,383
-785
-36% -$31K ﹤0.01% 2697
2024
Q1
$119K Buy
2,168
+2,102
+3,185% +$104K ﹤0.01% 2269
2023
Q4
$2.83K Buy
66
+31
+89% +$964 ﹤0.01% 3650
2023
Q3
$910 Sell
35
-20
-36% -$416 ﹤0.01% 3783
2023
Q2
$1.32K Sell
55
-75
-58% -$1.29K ﹤0.01% 3774
2023
Q1
$1.78K Sell
130
-309
-70% -$4.92K ﹤0.01% 3783
2022
Q4
$6.09K Buy
+439
New +$6.2K ﹤0.01% 3450

Other funds holding BHVN

US Bancorp's BHVN Position: Q2 2026 in Review

US Bancorp increased its Biohaven (BHVN) stake by 48% in Q2 2026, buying an estimated $10.3K and bringing the position to 2,977 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

US Bancorp first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $119K in Q1 2024. 294 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • US Bancorp held 2,977 shares of Biohaven worth $44.3K as of Q2 2026.
  • US Bancorp bought 959 Biohaven shares in Q2 2026, an estimated $10.3K.
  • Biohaven made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2855 holding.
  • US Bancorp first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • US Bancorp's Biohaven position peaked at $119K in Q1 2024.
  • 294 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.